INVL Private Equity Fund II, IFC and ACP Invest in POLMED to Acquire KN Group
October 2, 2025
INVL Private Equity Fund II, together with the International Finance Corporation (IFC) and Accession Capital Partners (ACP), entered into an investment agreement with POLMED to provide expansion capital. The funding is intended to finance POLMED’s acquisition of KN Group, a private oncology center operating facilities in Radom and Warsaw.
- Buyers
- INVL Private Equity Fund II, International Finance Corporation (IFC), Accession Capital Partners (ACP)
- Targets
- POLMED, KN Group
- Platforms
- POLMED
- Industry
- Healthcare Services
- Location
- Poland
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
PC Capital Invests in Polar (hospital platform)
October 1, 2023
Healthcare Services
PC Capital Development Fund II, L.P. completed an investment in Polar (Polar Salud), a platform that acquires and operates private hospitals across Latin America to provide affordable, high-quality care. The investment will support Polar’s organic and inorganic growth as a consolidator of hospital services, improving operations through centralized management and cost efficiencies.
-
Accelmed Partners Makes $35M Growth Investment in SKNV
November 14, 2022
Healthcare Services
Accelmed Partners completed a $35 million growth investment in SKNV Inc., a Florida-based dermatology digital health company and FDA-registered 503B outsourcing facility that supplies customized medications and an ecommerce/in-practice dispensing platform. Proceeds will fund a new manufacturing facility in Florida, scale SKNV's proprietary digital platform, expand its U.S. sales footprint, and add strategic management hires.
-
KKR and Impilo Acquire Immedica Pharma
January 24, 2025
Pharmaceuticals
KKR and Nordic healthcare investor Impilo have completed a joint acquisition of Stockholm-based Immedica Pharma, with Immedica management reinvesting alongside the new owners. Immedica is a commercial-stage pharmaceutical company focused on rare and specialty diseases (notably hematology, oncology and genetic/metabolic disorders) with ~€100m revenue and more than 120 employees; CVC Credit provided debt financing and Impilo used a single-asset continuation fund supported by secondary investors.
-
Infab (HKW Portfolio) Acquires Glove Division of International Biomedical, Ltd.
April 20, 2022
Medical Devices
Infab, a portfolio company of private equity firm HKW, has acquired the glove division of International Biomedical, Ltd. as an add-on to expand Infab's radiation-protection product offering and customer base; financial terms were not disclosed. The acquisition brings a complementary radiation-protection glove product line into Infab's PPE portfolio to better serve hospitals and imaging/surgical customers.
-
MidEuropa Acquires Majority Stake in the MBL Group
December 19, 2025
Medical Devices
MidEuropa has acquired a majority stake in the MBL Group, a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation and aged-care equipment. INVL Baltic Sea Growth Fund has fully exited its shareholding while the Lauritsen family has reinvested and CEO Martin Lauritsen will continue to lead the business as MidEuropa supports international growth and capability expansion. MBL employs approximately 1,700 people across Europe and Asia and holds over 100 registered patents.
-
IK Partners Acquires Medica Group
July 7, 2023
Healthcare Services
IK Partners, via newly incorporated Moonlight Bidco Limited, has completed its acquisition of Medica Group Plc, a market-leading teleradiology and imaging-services provider headquartered in Hastings, UK. The transaction (effective 6 July 2023) takes Medica private; IK says it will support Medica's growth by investing in people, technology and new capabilities, including through M&A.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.